Beam Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | — | $147.9M |
| Mar 2019 | — | — | $156.1M |
| Jun 2019 | — | — | $37.9M |
| Sep 2019 | — | — | $37.8M |
| Dec 2019 | $55.2M | $156.1M | $37.2M |
| Mar 2020 | $61.2M | $322.6M | $126.1M |
| Jun 2020 | $69.2M | $300.0M | $125.3M |
| Sep 2020 | $78.2M | $278.3M | $137.9M |
| Dec 2020 | $206.1M | $451.7M | $162.2M |
| Mar 2021 | $270.8M | $693.2M | $97.2M |
| Jun 2021 | $344.5M | $893.1M | $212.0M |
| Sep 2021 | $302.7M | $1.16B | $612.0M |
| Dec 2021 | $647.7M | $1.47B | $560.0M |
| Mar 2022 | $624.3M | $1.45B | $296.8M |
| Jun 2022 | $618.2M | $1.42B | $265.6M |
| Sep 2022 | $635.8M | $1.35B | $156.5M |
| Dec 2022 | $608.2M | $1.34B | $232.8M |
| Mar 2023 | $570.8M | $1.33B | $249.8M |
| Jun 2023 | $542.2M | $1.35B | $225.5M |
| Sep 2023 | $511.6M | $1.29B | $169.0M |
| Dec 2023 | $478.4M | $1.46B | $435.9M |
| Mar 2024 | $446.3M | $1.36B | $287.8M |
| Jun 2024 | $407.2M | $1.26B | $292.8M |
| Sep 2024 | $380.1M | $1.17B | $230.2M |
| Dec 2024 | $370.3M | $1.10B | $282.0M |
| Mar 2025 | $343.8M | $1.47B | $527.9M |
| Jun 2025 | $344.3M | $1.39B | $282.1M |
| Sep 2025 | $345.1M | $1.31B | $268.0M |
| Dec 2025 | $242.8M | $1.48B | $294.9M |
| Mar 2026 | $316.4M | $1.48B | $288.3M |
| Jun 2026 | $318.9M | $1.39B | $219.8M |